NCT07623148 GLP-1 RA Cessation and Gastric Ultrasound Findings
| NCT ID | NCT07623148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wonkwang University Hospital |
| Condition | Residual Gastric Contents |
| Study Type | OBSERVATIONAL |
| Enrollment | 186 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2026-07-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 186 participants in total. It began in 2026-07-01 with a primary completion date of 2026-07-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study will evaluate the association between the time interval since the last dose of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and residual gastric contents before elective surgery. Adult patients receiving GLP-1 RAs and scheduled for elective non-cardiac surgery under general anesthesia will undergo preoperative point-of-care gastric ultrasound. The study will assess whether longer GLP-1 RA cessation intervals are associated with lower ultrasound-estimated gastric volume and a lower frequency of high-risk gastric contents. Body mass index will also be evaluated as a potential modifier of this association.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older. * Patients receiving a glucagon-like peptide-1 receptor agonist. * Patients scheduled for elective non-cardiac surgery requiring general anesthesia. * Patients able to provide written informed consent. Exclusion Criteria: * Emergency surgery. * History of prior gastric surgery. * Known gastroparesis or severe gastroesophageal reflux disease. * Declined or unable to provide written informed consent.
Contact & Investigator
Cheol Lee, M.D.,Ph.D
STUDY DIRECTOR
Wonkwang University Hosptial
Frequently Asked Questions
Who can join the NCT07623148 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 65 Years, studying Residual Gastric Contents. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07623148 currently recruiting?
Yes, NCT07623148 is actively recruiting participants. Contact the research team at ironyii70@gmail.com for enrollment information.
Where is the NCT07623148 trial being conducted?
This trial is being conducted at Iksan, South Korea.
Who is sponsoring the NCT07623148 clinical trial?
NCT07623148 is sponsored by Wonkwang University Hospital. The principal investigator is Cheol Lee, M.D.,Ph.D at Wonkwang University Hosptial. The trial plans to enroll 186 participants.